Active Volume Stock: Synergy Pharmaceuticals, Inc. (SGYP)

41
amazon quarterly result

Synergy Pharmaceuticals, Inc. (SGYP) belonging to the Healthcare sector has declined -10.29% and closed its last trading session at $2.44.

The company reported its EPS on 9/29/2017. Currently, the stock has a 1 Year Price Target of $8.42.

The consensus recommendation, according to Zacks Investment research, is 2. The scale runs from 1 to 5 with 1 recommending Strong Buy and 5 recommending a Strong Sell.

The Stock had a 2 Consensus Analyst Recommendation 30 Days Ago, whereas 60 days ago and 90 days ago the analyst recommendations were 1.8 and 2 respectively.

Synergy Pharmaceuticals, Inc. on 9/29/2017 reported its EPS as $-0.31 with the analysts projecting the EPS of the stock as $-0.2. The company beat the analyst EPS Estimate with the difference of $-0.11. This shows a surprise factor of -0.55%.

Many analysts have provided their estimated foresights on Synergy Pharmaceuticals, Inc. Earnings, with 6 analysts believing the company would generate an Average Estimate of $-0.22.

Whereas they predicted High and Low Earnings Estimate as $-0.2 and $-0.28 respectively. While in the same Quarter Previous year, the Actual EPS was $-0.31.

Analysts are also projecting an Average Revenue Estimate for Synergy Pharmaceuticals, Inc. as $7360 in the Current Quarter. This estimate is provided by 5 analysts.

For the Current Quarter, the growth estimate for Synergy Pharmaceuticals, Inc. is 29%, while for the Next Quarter the stock growth estimate is 30%.

Insider Trades for Synergy Pharmaceuticals, Inc. show that the latest trade was made on 6 Aug 2017 where PAULSON & CO INC, the Beneficial Owner of More than 10% Class completed a transaction type “Sell” in which 87 shares were traded at a price of $3.78.

Synergy Pharmaceuticals, Inc. (SGYP) has the market capitalization of $599.34 Million. The company rocked its 52-Week High of $7.15 and touched its 52-Week Low of $2.42.

The stock has Return on Assets (ROA) of -195.9 percent. Return on Equity (ROE) stands at -540.2% and Return on Investment (ROI) of 0 percent.

The stock is currently showing YTD performance of -59.93 Percent. The company has Beta Value of 1.34 and ATR value of 0.2. The Weekly and Monthly Volatility stands at 9.32% and 7.05%.